Can soy phytoestrogens decrease DNA methylation in BRCA1 and BRCA2 oncosuppressor genes in breast cancer?

OMICS A Journal of Integrative Biology

Volumn 16, Issue 5, 2012, Pages 235-244

  Bosviel, Rémy ^a,b   Dumollard, Elise ^a,b   Déchelotte, Pierre ^b,c   Bignon, Yves Jean ^a,b   Bernard Gallon, Dominique ^a,b  

^a CENTRE JEAN PERRIN   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; BUDESONIDE; DAIDZEIN; GENISTEIN; PHYTOESTROGEN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; BUDESONIDE; CELL LINE, TUMOR; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENISTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; ISOFLAVONES; PHYTOESTROGENS; SOYBEANS;

EID: 84860734987     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2011.0105     Document Type: Article

References (46)

1. Adlercreutz, H., and Mazur, W. (1997). Phyto-oestrogens and Western diseases. Ann. Med. 29, 95-120. (Pubitemid 27226319)
2. Billard, L.M., Magdinier, F., Lenoir, G.M., Frappart, L., and Dante, R. (2002). MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland. Oncogene 21, 2704-2712. (Pubitemid 34478328)
3. Brzezinski, A., and Debi, A. (1999). Phytoestrogens: The ''natural'' selective estrogen receptor modulators? Eur. J. Obstet. Gynecol. Reprod. Biol. 85, 47-51. (Pubitemid 29248782)
4. Cailleau, R., Young, R., Olive, M., and Reeves, W.J., Jr. (1974). Breast tumor cell lines from pleural effusions. J. Natl. Cancer Inst. 53, 661-674.
5. Catteau, A., Harris, W.H., Xu, C.F., and Solomon, E. (1999). Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: Correlation with disease characteristics. Oncogene 18, 1957-1965. (Pubitemid 29150082)
6. Cucer, N., Taheri, S., Ok, E., and Ozkul, Y. (2008). Methylation status of CpG islands at sites - 59 to + 96 in exon 1 of the BRCA2 gene varies in mammary tissue among women with sporadic breast cancer. J. Genet. 87, 155-158.
7. Day, J.K., Bauer, A.M., Desbordes, C., Zhuang, Y., Kim, B.E., Newton, L.G., et al. (2002). Genistein alters methylation patterns in mice. J. Nutr. 132, 2419S-2423S. (Pubitemid 34848119)
8. Dobrovic, A., and Simpfendorfer, D. (1997). Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res. 57, 3347-3350. (Pubitemid 27355472)
9. Dolinoy, D.C., Weidman, J.R., Waterland, R.A., and Jirtle, R.L. (2006). Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ. Health Perspect. 114, 567-572.
10. Elsheikh, S.E., Green, A.R., Rakha, E.A., Powe, D.G., Ahmed, R.A., Collins, H.M., et al. (2009). Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res. 69, 3802-3809.
11. Esteller, M. (2007). Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet. 8, 286-298. (Pubitemid 46439286)
12. Esteller, M., Silva, J.M., Dominguez, G., Bonilla, F., Matias-Guiu, X., Lerma, E., et al. (2000). Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J. Natl. Cancer Inst. 92, 564-569. (Pubitemid 30212318)
13. Fang, M., Chen, D., and Yang, C.S. (2007). Dietary polyphenols may affect DNA methylation. J. Nutr. 137, 223S-228S.
14. Fang, M.Z., Chen, D., Sun, Y., Jin, Z., Christman, J.K., and Yang, C.S. (2005). Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin. Cancer Res. 11, 7033-7041. (Pubitemid 41428763)
15. Ferlay, J., Parkin, D.M., and Steliarova-Foucher, E. (2010). Estimates of cancer incidence and mortality in Europe in 2008. Eur. J. Cancer 46, 765-781.
16. Hedenfalk, I., Duggan, D., Chen, Y., Radmacher, M., Bittner, M., Simon, R., et al. (2001). Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med. 344, 539-548. (Pubitemid 32167867)
17. King-Batoon, A., Leszczynska, J.M., and Klein, C.B. (2008). Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environ. Mol. Mutagen. 49, 36-45. (Pubitemid 351293011)
18. Koch, C., and Stratling, W.H. (2004). DNA binding of methyl-CpG-binding protein MeCP2 in human MCF7 cells. Biochemistry 43, 5011-5021. (Pubitemid 38544455)
19. Kuiper, G.G., Carlsson, B., Grandien, K., Enmark, E., Haggblad, J., Nilsson, S., et al. (1997). Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138, 863-870. (Pubitemid 27089735)
20. Kuiper, G.G., Lemmen, J.G., Carlsson, B., Corton, J.C., Safe, S.H., Van der Saag, P.T., et al. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139, 4252-4263. (Pubitemid 28513713)
21. Lee, M.N., Tseng, R.C., Hsu, H.S., Chen, J.Y., Tzao, C., Ho, W.L., et al. (2007). Epigenetic inactivation of the chromosomal stability control genes BRCA1, BRCA2, and XRCC5 in non-small cell lung cancer. Clin. Cancer Res. 13, 832-838. (Pubitemid 46340356)
22. Li, Y., Liu, L., Andrews, L.G., and Tollefsbol, T.O. (2009). Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms. Int. J. Cancer 125, 286-296.
23. Li, Y., and Tollefsbol, T.O. (2010). Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components. Curr. Med. Chem. 17, 2141-2151.
24. Liu, Z.H., Kanjo, Y., and Mizutani, S. (2010). A review of phytoestrogens: Their occurrence and fate in the environment. Water Res. 44, 567-577.
25. Lyn-Cook, B.D., Blann, E., Payne, P.W., Bo, J., Sheehan, D., and Medlock, K. (1995). Methylation profile and amplification of proto-oncogenes in rat pancreas induced with phytoestrogens. Proc. Soc. Exp. Biol. Med. 208, 116-119.
26. Majid, S., Dar, A.A., Ahmad, A.E., Hirata, H., Kawakami, K., Shahryari, V., et al. (2009). BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis 30, 662-670.
27. Mancini, D.N., Rodenhiser, D.I., Ainsworth, P.J., O'Malley, F.P., Singh, S.M., Xing, W., et al. (1998). CpG methylation within the 5cent; regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene 16, 1161-1169. (Pubitemid 28127515)
28. Messina, M., and Wu, A.H. (2009). Perspectives on the soy-breast cancer relation. Am. J. Clin. Nutr. 89, 1673S-1679S.
29. Miller, O.J., Schnedl, W., Allen, J., and Erlanger, B.F. (1974). 5-Methylcytosine localised in mammalian constitutive heterochromatin. Nature 251, 636-637.
30. Mirza, S., Sharma, G., Pandya, P., and Ralhan, R. (2010). Demethylating agent 5-Aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents. Mol. Cell. Biochem. 342, 101-109.
31. Muller, H.M., Fiegl, H., Goebel, G., Hubalek, M.M., Widschwendter, A., Muller-Holzner, E., et al. (2003). MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status. Br. J. Cancer 89, 1934-1939. (Pubitemid 37533273)
32. Oseni, T., Patel, R., Pyle, J., and Jordan, V.C. (2008). Selective estrogen receptor modulators and phytoestrogens. Planta Med. 74, 1656-1665.
33. Pfitscher, A., Reiter, E., and Jungbauer, A. (2008). Receptor binding and transactivation activities of red clover isoflavones and their metabolites. J. Steroid Biochem. Mol. Biol. 112, 87-94.
34. Qin, W., Zhu, W., Shi, H., Hewett, J.E., Ruhlen, R.L., MacDonald, R.S., et al. (2009). Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women. Nutr. Cancer 61, 238-244.
35. Rice, J.C., Massey-Brown, K.S., and Futscher, B.W. (1998). Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene 17, 1807-1812. (Pubitemid 28482783)
36. Rice, J.C., Ozcelik, H., Maxeiner, P., Andrulis, I., and Futscher, B.W. (2000). Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. Carcinogenesis 21, 1761-1765.
37. Rossetto, D., Truman, A.W., Kron, S.J., and Cote, J. (2010). Epigenetic modifications in double-strand break DNA damage signaling and repair. Clin Cancer Res 16, 4543-4552.
38. Setchell, K.D. (2001). Soy isoflavones-benefits and risks from nature's selective estrogen receptor modulators (SERMs). J. Am. Coll. Nutr. 20, 354S-362S; discussion 381S-383S. (Pubitemid 32948014)
39. Soule, H.D., Vazguez, J., Long, A., Albert, S., and Brennan, M. (1973). A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51, 1409-1416.
40. Soule, H.D., Maloney, T.M., Wolman, S.R., Peterson, W.D., Jr., Brenz, R., McGrath, C.M., et al. (1990). Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50, 6075-6086. (Pubitemid 20331424)
41. Takeuchi, S., Takahashi, T., Sawada, Y., Iida, M., Matsuda, T., and Kojima, H. (2009). Comparative study on the nuclear hormone receptor activity of various phytochemicals and their metabolites by reporter gene assays using Chinese hamster ovary cells. Biol. Pharm. Bull. 32, 195-202.
42. Tost, J. (2010). DNA methylation: An introduction to the biology and the disease-Associated changes of a promising biomarker. Mol. Biotechnol. 44, 71-81.
43. Vissac-Sabatier, C., Bignon, Y.J., and Bernard-Gallon, D.J. (2003). Effects of the phytoestrogens genistein and daidzein on BRCA2 tumor suppressor gene expression in breast cell lines. Nutr. Cancer 45, 247-255. (Pubitemid 37022799)
44. Wessels, L.F., Van Welsem, T., Hart, A.A., Van't Veer, L.J., Reinders, M.J., and Nederlof, P.M. (2002). Molecular classification of breast carcinomas by comparative genomic hybridization: A specific somatic genetic profile for BRCA1 tumors. Cancer Res. 62, 7110-7117. (Pubitemid 35424107)
45. Wu, C., and Morris, J.R. (2001). Genes, genetics, and epigenetics: A correspondence. Science 293, 1103-1105. (Pubitemid 32758084)
46. Zhao, Y., Leung, P.C., Woo, K.S., Chen, G.G., Wong, Y.O., Liu, S.X., et al. (2004). Inhibitory effects of budesonide, desloratadine and dexamethasone on cytokine release from human mast cell line (HMC-1). Inflamm. Res. 53, 664-669. (Pubitemid 40174542)